CID 5272613

2.-alpha.,3-.beta.-,19.-beta,23-tetrahydroxyolean-12en-28oic acid 3-o-.beta.-d-galactopyranosyl-(1-3)-.beta.-d-glucopydranoside-28-o-.beta.-d-glucopyranoside

Structural Information

Molecular Formula
C48H78O21
SMILES
C[C@@]12CC[C@@H]3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@H]4[C@@H](C(CC5)(C)C)O)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)(C[C@H]([C@@H]([C@@]3(C)CO)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)C
InChI
InChI=1S/C48H78O21/c1-43(2)11-13-48(42(63)69-40-34(60)32(58)29(55)23(17-50)65-40)14-12-46(5)20(27(48)37(43)62)7-8-26-44(3)15-21(53)38(45(4,19-52)25(44)9-10-47(26,46)6)68-41-35(61)36(30(56)24(18-51)66-41)67-39-33(59)31(57)28(54)22(16-49)64-39/h7,21-41,49-62H,8-19H2,1-6H3/t21-,22-,23-,24-,25-,26-,27-,28-,29-,30+,31+,32+,33-,34-,35-,36+,37+,38+,39+,40+,41+,44+,45+,46-,47-,48+/m1/s1
InChIKey
NSZSDRNMXRQQMG-LPDIUYJMSA-N
Compound name
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10-[(2R,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

990.50354 Da
Monoisotopic Mass

-1.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 991.51082 310.4
[M+Na]+ 1013.4928 312.2
[M-H]- 989.49626 305.5
[M+NH4]+ 1008.5374 310.1
[M+K]+ 1029.4667 303.6
[M+H-H2O]+ 973.50080 305.5
[M+HCOO]- 1035.5017 310.6
[M+CH3COO]- 1049.5174 312.8
[M+Na-2H]- 1011.4782 335.3
[M]+ 990.50299 310.7
[M]- 990.50409 310.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.